Cartesian Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $102k | 9.9k | 10.22 |
| 2025-06-30 | $137k | 13k | 10.39 |
| 2025-03-31 | $410k | 31k | 13.18 |
| 2024-12-31 | $315k | 18k | 17.91 |
| 2024-09-30 | $86k | 5.3k | 16.12 |
| 2024-06-30 | $60k | 2.2k | 27.00 |